Imaging correlates of decreased axonal Na + /K + ATPase in chronic multiple sclerosis lesions
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: Degeneration of chronically demyelinated axons is a major cause of irreversible neurological decline in the human central nervous system disease, multiple sclerosis (MS). Although the molecular mechanisms responsible for this axonal degeneration remain to be elucidated, dysfunction of axonal Na + /K + ATPase is thought to be central. To date, however, the distribution of Na + /K + ATPase has not been studied in MS lesions. Methods: The percentage of axons with detectable Na + /K + ATPase was determined in 3 acute and 36 chronically demyelinated lesions from 13 MS brains. In addition, we investigated whether postmortem magnetic resonance imaging profiles could predict Na + /K + ATPase immunostaining in a subset (20) of the chronic lesions. Results: Na + /K + ATPase subunits α1, α3, and β1 were detected in the internodal axolemma of myelinated fibers in both control and MS brains. In acutely demyelinated lesions, Na + /K + ATPase was detectable on demyelinated axolemma. In contrast, 21 of the 36 chronic lesions (58%) contained less than 50% Na + /K + ATPase‐positive demyelinated axons. In addition, magnetic resonance imaging‐pathology correlations of 20 chronic lesions identified a linear decrease in the percentage of Na + /K + ATPase‐positive axons and magnetization transfer ratios ( p < 0.0001) and T1 contrast ratios ( p < 0.0006). Interpretation: Chronically demyelinated axons that lack Na + /K + ATPase cannot exchange axoplasmic Na + for K + and are incapable of nerve transmission. Loss of axonal Na + /K + ATPase is likely to be a major contributor to continuous neurological decline in chronic stages of MS, and quantitative magnetization transfer ratios and T1 contrast ratios may provide a noninvasive surrogate marker for monitoring this loss in MS patients. Ann Neurol 2008;63:428–435
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991 · cited 2×
“Sections were stained for myelin proteins and major histocompatability complex class II, and classified as acute, chronic active or chronic inactive, as described previously.(19) Three acute and 36 chronic lesions were identified.”
MethodSelf-citationStys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Einheber, S., Zanazzi, G., Ching, W., Scherer, S., Milner, T. A., Peles, E., & Salzer, J. L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.6.1495 · Cited by 369
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Self-citationRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
“, are sufficient (although the insertion of Na + channels can be compromised in chronically demyelinated axons owing to inadequate axolemmal expression of the Na + –K + ATPase, the enzyme that is responsible for rapidly correcting Na + and K + levels following an action potential and thereby for allowing repetitive ax…”
BackgroundMyelination and the trophic support of long axons
Nave, K.-A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2797 · Cited by 648
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Self-citationProgressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
The energetics of CNS white matter
Harris, J. J., & Attwell, D. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3430-11.2012 · Cited by 505
“…then spread along the internode (although some K may diffuse to the extracellular space at the node), ultimately being pumped back across the membrane by axonal membrane Na /K pumps, which are located all along the internode (Mata et al., 1991; Young et al., 2008; but see Ariyasu et al., 1985).”
BackgroundWill the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Self-citationMitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
“…IV dysfunction involves Na+/K+ ATPase -positive demyelinated axons We determined the implications of a complex IV defect for nerve impulse transmission by identifying the population of Na+/K+ ATPase α-1 positive axons in chronic lesions, as Na+/ K+ ATPase is energy dependent (Young et al., 2008).”
InfluentialOligodendroglia: metabolic supporters of neurons
Philips, T., & Rothstein, J. D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90610 · Cited by 342
The role of myelin and oligodendrocytes in axonal energy metabolism
Saab, A. S., Tzvetanova, I. D., & Nave, K.-A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.09.008 · Cited by 324
Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations
Moll, N. M., Rietsch, A. M., Thomas, S., Ransohoff, A. J., Lee, J., Fox, R., Chang, A., Ransohoff, R. M., & Fisher, E. (2011) · Annals of Neurology · doi:10.1002/ana.22521 · Cited by 297
“However, additional pathologic features may contribute to the MTR signal.(27,32,34) When we excluded lesions from the analysis, MTR was no longer correlated with myelin density, suggesting that other pathologic processes were responsible for MTR differences in NAWM.”
BackgroundSelf-citationBurkholder, B. M., Osborne, B., Loguidice, M. J., Bisker, E., Frohman, T. C., Conger, A., Ratchford, J. N., Warner, C., Markowitz, C. E., Jacobs, D. A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.230 · Cited by 199
Review: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Trapp, B. D., Vignos, M., Dudman, J., Chang, A., Fisher, E., Staugaitis, S. M., Battapady, H., Mork, S., Ontaneda, D., Jones, S. E., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30245-x · Cited by 146
Self-citationMechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities
Macrez, R., Stys, P. K., Vivien, D., Lipton, S. A., & Docagne, F. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30165-x · Cited by 127
van Hameren, G., Campbell, G., Deck, M., Berthelot, J., Gautier, B., Quintana, P., Chrast, R., & Tricaud, N. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0740-4 · Cited by 83
Nuzziello, N., Vilardo, L., Pelucchi, P., Consiglio, A., Liuni, S., Trojano, M., & Liguori, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113652 · Cited by 46
“Finally, ADD2 showed interactions with the alpha subunit of the Na+/K+-ATPase [45], whose dysfunction at the axonal level has been indicated as a major contributor to the progressive neurological decline observed in the chronic phases of MS [46].”
Background
Metadata
- Authors
- Young, E. A., Fowler, C. D., Kidd, G. J., Chang, A., Rudick, R., Fisher, E., & Trapp, B. D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-04
- Volume
- 63
- Issue
- 4
- Pages
- 428-435
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2162846503
- Cited by
- 111
- References
- 6
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.